These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Sequential RAAS blockade: is it worth the risk? Persson F; Rossing P Adv Chronic Kidney Dis; 2014 Mar; 21(2):159-65. PubMed ID: 24602465 [TBL] [Abstract][Full Text] [Related]
9. Slowing Progression in CKD: DAPA CKD and Beyond. Larmour K; Levin A Clin J Am Soc Nephrol; 2021 Jul; 16(7):1117-1119. PubMed ID: 33692116 [No Abstract] [Full Text] [Related]
10. Renal effects of dual renin-angiotensin-aldosterone system blockade in patients with diabetic nephropathy. Dalla Vestra M; Simioni N; Masiero A Int Urol Nephrol; 2009; 41(1):119-26. PubMed ID: 18958580 [TBL] [Abstract][Full Text] [Related]
12. Dual renin-angiotensin system blockade for nephroprotection: still under scrutiny. Gentile G; Remuzzi G; Ruggenenti P Nephron; 2015; 129(1):39-41. PubMed ID: 25531311 [TBL] [Abstract][Full Text] [Related]
13. Comprehensive suppression of the renin-angiotensin-aldosterone system in chronic kidney disease: covering all of the bases. Weinberger MH; Luft FC Kidney Int; 2006 Dec; 70(12):2051-3. PubMed ID: 17136130 [TBL] [Abstract][Full Text] [Related]
14. Renin angiotensin system blockade and nephropathy: why is it being called into question, and should it be? Hollenberg NK; Epstein M Clin J Am Soc Nephrol; 2006 Sep; 1(5):1046-8. PubMed ID: 17699325 [No Abstract] [Full Text] [Related]
15. Renoprotection by blocking the RAAS in diabetic nephropathy--fact or fiction? Rossing P; Parving HH; de Zeeuw D Nephrol Dial Transplant; 2006 Sep; 21(9):2354-7; discussion 2357-8. PubMed ID: 16928724 [No Abstract] [Full Text] [Related]
16. The renin-angiotensin system and diabetic nephropathy. Gurley SB; Coffman TM Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683 [TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme inhibitors or angiotensin II receptor blockers for prevention and treatment of nephropathy associated with type 2 diabetes mellitus. Hughes DB; Britton ML Pharmacotherapy; 2005 Nov; 25(11):1602-20. PubMed ID: 16232022 [TBL] [Abstract][Full Text] [Related]